Ergomed has released detailed FY 22 results following its trading update on January 31st, reflecting strong revenue growth and stable service fee gross profit margins. Expansion in the orderbook provides visibility for growth in the next year. The balance sheet is net cash, providing optionality on acquisition growth.
Davy research
Davy ResearchOcado Group - A digital-super-market-market
Davy ResearchDatalex - At an inflection point
Davy ResearchGreencore Group - Resilient H1 performance underpins FY23 outlook
Davy ResearchARYZTA - Strong performance continues
Davy ResearchFast Fashion - Fashion players’ forecast update: 2023, the year of… cashflow?
Davy ResearchDisruptive technology - Week 20 – US Bellwether Blast: Nvidia’s Q124 earnings
Davy ResearchMarket comment - Investors add to bets Bank of England to hike aggressively
Davy ResearchLufthansa - Lufthansa-ITA transaction positive for the industry